Kessler Paul D. 4
4 · NABI BIOPHARMACEUTICALS · Filed Mar 31, 2011
Insider Transaction Report
Form 4
Kessler Paul D.
SVP Clinical, Med. & Reg.; CMO
Transactions
- Award
Stock Option (right to buy)
2010-03-15+1,000→ 1,000 totalExercise: $5.86Exp: 2017-03-15→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]The Stock Option (right to buy) is exercisable in four equal installments on March 15, 2011, March 15, 2012, March 15, 2013 and March 15, 2014.